Alzheimers News
-
Highly Processed Foods Are Bad for Older Brains, Study Says
A diet rich in chips, cookies, hot dogs, and other highly processed foods is harmful for the aging brain, according to a new study presented at the Alzheimer's Association International Conference.
-
Diets Heavy in 'Ultra-Processed' Foods Could Harm the Brain
According to a new study, eating lots of ultra-processed foods may dramatically increase your risk for dementia.
-
Scientists Find Brain Mechanism Behind Age-Related Memory Loss
Discovery could lead to new dementia treatments or even help prevent cognitive decline in the first place, Johns Hopkins researchers say.
-
Do I Have Alzheimer’s Disease? Just One Brain Scan May Tell
The tool could also tell the difference between early and late-stage dementia in 79% of cases.
-
Dementia Linked to Vitamin D Deficiency, Study Shows
Boosting low vitamin D levels to normal ranges could help protect the brain against a loss of thinking skills as people age, the study authors wrote.
-
Mutant Gene Stops At-Risk People From Getting Alzheimer's
Learning more about this gene may lead to future treatments.
-
Holistic Program May Help People With Alzheimer's, Dementia
Those who enroll are assigned to groups that meet virtually twice a week for 1-hour sessions. The sessions are livestreamed, so participants are engaging with each other and with the instructors in real time.
-
FDA OKs Diagnostic Test for Early Alzheimer's
The FDA has cleared the first in vitro diagnostic test for early detection of Alzheimer's disease.
-
Race Plays Huge Role in Dementia Risk
A large new study finds Black, Hispanic and Asian Americans have an increased risk of being diagnosed with dementia, but the reasons why are unclear.
-
Certain Rheumatoid Arthritis Meds May Help Lower Alzheimer's Risk
Early research suggests a type of RA drug known as TNF inhibitors may lower dementia risk in people who have RA and heart disease.
-
Medicare Will Only Cover New Alzheimer’s Drug in Trials
Federal officials have made their final decision: Medicare will only pay for patients to get the new Alzheimer's drug aducanumab (Aduhelm) if the patients are participating in clinical trials.
-
More Evidence That Education May Protect Against Dementia
A new study finds education and language skills can help predict who will go on to develop dementia and who won't.
-
Could Viagra Help Prevent Alzheimer's?
researchers found that those taking Viagra were 69% less likely to develop Alzheimer's, when compared to non-users. And lab experiments showed that the medication seemed to target part of the underlying disease process in Alzheimer's.
-
Trial Begins of Nasal Vaccine for Alzheimer's Disease
The vaccine stimulates the immune system, prompting white blood cells to migrate to the brain and clear beta amyloid plaques.
-
Many People May Be Eating Their Way to Dementia
New research suggests a diet is loaded with pro-inflammatory foods may increase your risk for memory loss, issues with language, problem-solving and other thinking skills as you age.
-
Depression in Early Life May Up Dementia Risk Later
A new study suggests that if you're depressed as a young adult, your odds for dementia rise.
-
Some Diabetes Meds Might Also Lower Alzheimer's Risk
A new study suggests older adults who take certain diabetes drugs may see a slower decline in their memory and thinking skills.
-
Dirty Air, Higher Dementia Risk?
A long-term study links exposure to higher levels of fine particulate air pollution to an increased risk of dementia.
-
An ALS Drug Shows Early Promise Against Alzheimer's
Studies show the drug Riluzole which is used to slow the progression of ALS may have positive effects on cognition in people with mild Alzheimer's.
-
Medicare Mulls Coverage for New Alzheimer's Drug
Medicare launched a formal process that will determine whether the agency will cover Aduhelm, the newly approved Alzheimer's drug whose high price tag and unproven benefits have prompted widespread controversy.
-
FDA Head Calls for Inquiry Into Alzheimer's Drug Approval
Following the FDA’s controversial approval of aducanumab for Alzheimer's, the head of the agency is now calling for a federal investigation into its own approval proceedings.
-
Controversial New Alzheimer's Drug: Why Some Patients Say Yes
As advocates and critics debate the FDA's approval of the new drug, and a chorus of experts and patient advocates protest the price, many patients and their families are excited about it, hopeful that it will stop the debilitating disease from getting worse .
-
First Patient Gets Biogen’s New Alzheimer’s Drug
A man has received the first infusion of a new Alzheimer’s drug that drew criticism from some doctors after its FDA approval last week.
-
Group Wants FDA Leaders Ousted Over Alzheimer's Drug Approval
A consumer advocacy group is calling for the removal of three top FDA officials, saying the agency's approval of the Alzheimer's drug aducanumab (Aduhelm) was "reckless."
-
Controversial New Alzheimer's Drug: What to Know
As the first Alzheimer's drug approved since 2003, advocates applaud the decision. Critics say the approval was based on inadequate proof that the drug works and balk at the price tag of $56,000 a year.
Pagination